NOVEL MINIMAL SURFACE AREA COLLECTION DEVICE AND RAPID METHOD FOR ESTIMATING LOW BLOOD VOLUME

Abstract

An insert for a holding device for reliably and accurately assessing a small volume of blood in a fluid, such as in a volume of surgical fluid collected during a surgical procedure, is provided. The insert may include a circular shelf having an outside perimeter configured to fit up against an inside perimeter of a holding device. The insert may include a center opening. The insert may include a conically-shaped collection cone disposed in the center opening. The collection cone may include a length, an interior surface comprising a red blood cell flocculant coating, a gradually decreasing perimeter terminating in a bottom apex, and a series of graduated volumetric markings along the length of the collection cone.

Claims

1. A conical collection device configured to measure a small volume of blood in a fluid, wherein the conical collection device comprises: shelf material having an outside perimeter configured to fit up against an inside perimeter of a holding device; and having an opening configured to receive an open top end of a conical-shaped fluid collection cone; and a conical-shaped fluid collection cone, said collection cone comprising: a top end configured to fit within the opening of the shelf material, a length, an interior surface, a gradually decreasing perimeter starting at the top end and terminating in a bottom apex, and a series of markings along the length of the collection cone corresponding to a measure of sedimented red blood cell volume, the sedimented red blood cell volume corresponding to a calculated blood volume in the collection cone.

2. The conical collection device of claim 1, wherein the interior surface of the conical-shaped fluid collection cone comprises a red blood cell flocculant.

3. The conical collection device of claim 2, wherein the red blood cell flocculant is polyDADMAC.

4. The conical collection device of claim 1, wherein the graduated markings are provided along the interior surface or an exterior surface of the conical-shaped collection cone.

5. The conical collection device of claim 1, wherein the shelf is integrally formed with the inside perimeter of the holding device.

6. The conical collection device of claim 1, configured to be removably inserted into the holding device.

7. The conical collection device of claim 1, wherein the conical-shaped fluid collection cone is transparent.

8-12. (canceled)

13. A method for assessing a small volume of blood in a fluid comprising: collecting a fluid in a conical collection device comprising a conical-shaped fluid collection cone, comprising: a length, a top, a bottom apex, and an interior surface, a gradually decreasing perimeter terminating in a bottom apex, and a series of markings for sedimented red blood cells along the length of the collection cone; and assessing a settled red blood cell volume within the collection cone and correlating the sedimented red blood cell volume of blood in the fluid, wherein the series of markings for sedimented red blood cells correlate with a calculated blood volume in a fluid.

14. The method of claim 13, wherein the conical collection device comprises a red blood cell flocculant.

15. The method of claim 13, wherein the assessing step occurs within about 5 minutes of the collecting step.

16. A kit for assessing a small volume of blood in a fluid, the kit comprising: a holding device, wherein the holding device comprises an interior space and an inside perimeter: shelf material having an outside perimeter configured to fit up against the inside perimeter of the holding device; a center opening and; and a conical-shaped collection cone disposed in said center opening of the holding device, said collection cone comprising: a length, an interior surface, the length of the conical-shaped collection cone having a gradually decreasing perimeter terminating in a bottom apex, and a series of graduated markings for sedimented red blood cells along the length of the collection cone; a lid configured to enclose the inside perimeter of the holding device, wherein the lid includes a first inlet port and a second inlet port; a first length of tubing configured for receiving a first fluid; and a second length of tubing configured for receiving a second fluid.

17. The kit of claim 16, comprising a red blood cell flocculant.

18-20. (canceled)

21. A blood measurement device configured to measure a volume of blood in a small fluid volume, wherein the blood measurement device comprises: a conical-shaped fluid collection cone comprising: a length having a top end and a bottom apex, the length of the cone having a gradually decreasing perimeter from the top end to the bottom apex, an interior surface, and a series of graduated volumetric markings along the length of the collection cone corresponding to a volumetric measure of sedimented red blood cells, the volume of sedimented red blood cells calibrated to define a blood volume in the device. wherein the blood volume measurement is calibrated to provide an about 3 ml detection level.

22. The blood fluid measurement device of claim 21 wherein the interior surface of the conical-shaped fluid collection cone comprises a coating of a red blood cell flocculant.

23. The blood fluid measurement device of claim 21 wherein the red blood cell flocculant comprises polyDADMAC.

24. The blood fluid measurement device of claim 21 wherein conical-shaped fluid collection cone has a total fluid volume capacity of about 250 ml.

25. The blood fluid measurement device of claim 21 wherein conical-shaped fluid collection cone has a total fluid volume capacity of about 500 ml.

26. The blood fluid measurement device of claim 21 wherein conical-shaped fluid collection cone has a total fluid volume capacity of about 1000 ml.

27. The blood fluid measurement device of claim 21 further defined as a pediatric blood fluid measurement device.

Description

DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING

[0023] In the accompanying drawing, which forms a part of the specification and is to be read in conjunction therewith in which like reference numerals are used to indicate like or similar parts in the various views:

[0024] FIG. 1 is a schematic perspective view of a collection device for determining the amount of blood volume within a volume of liquid in accordance with one embodiment of the present invention;

[0025] FIG. 2 is a schematic sectional view of the collection device of FIG. 1 taken along line 2-2 in the direction of the arrows;

[0026] FIG. 3 is a schematic partial perspective view of an insert for use in the collection device of FIG. 1;

[0027] FIG. 4 is a schematic perspective view of a collection device for determining the amount of blood volume within a volume of liquid in accordance with another embodiment of the present invention;

[0028] FIG. 5 is a schematic sectional view of the collection device of FIG. 4 taken along line 5-5 in the direction of the arrows;

[0029] FIG. 6 is a schematic partial perspective view of an insert for use in the collection device of FIG. 4;

[0030] FIG. 7 is a schematic perspective view of a collection device for determining the amount of blood volume within a volume of liquid in accordance with yet another embodiment of the present invention;

[0031] FIG. 8 is a schematic perspective view of a collection device for determining the amount of blood volume within a volume of liquid and having a RBC flocculant layer applied therein in accordance with one embodiment of the present invention; and

[0032] FIG. 9 is a schematic perspective view of a collection device for determining the amount of blood volume within a volume of liquid and having a RBC flocculant layer applied therein in accordance with another embodiment of the present invention.

DETAILED DESCRIPTION OF THE INVENTION

[0033] The invention will now be described with reference to the drawing figures, in which like reference numerals refer to like parts throughout. For purposes of clarity in illustrating the characteristics of the present invention, proportional relationships of the elements have not necessarily been maintained in the drawing figures.

[0034] The following detailed description of the invention references specific embodiments in which the invention can be practiced. The embodiments are intended to describe aspects of the invention in sufficient detail to enable those skilled in the art to practice the invention. Other embodiments can be utilized and changes can be made without departing from the scope of the present invention. The present invention is defined by the appended claims and the description is, therefore, not to be taken in a limiting sense and shall not limit the scope of equivalents to which such claims are entitled.

[0035] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of skill in the art to which the disclosure pertains. Although any methods and materials similar to or equivalent to those described herein can be used in the practice or testing of the present technology, the preferred methods and materials are described herein.

[0036] As used here, the term “flocculant” is intended to mean a molecule that has a cationic charge that is capable of facilitating the coalescence of RBCs in a fluid at room temperature, and form a settled RBC mass with less than 30 minutes at room temperature without centrifugation.

[0037] Reference to an element by the indefinite article “a” or “an” does not exclude the possibility that more than one element is present, unless the context clearly requires that there be one and only one element. The indefinite article “a” or “an” thus usually means “at least one.”

[0038] As used herein, “patient” or “subject” means an individual having symptoms of, or at risk for, cancer or other malignancy. A patient may be human or non-human and may include, for example, animal such a horse, dog, cow, pig or other animal. Likewise, a patient or subject may include a human patient including adults or juveniles (e.g., children). Moreover, a patient or subject may mean any living organism, preferably a mammal (e.g., human or non-human) from whom a blood volume is desired to be determined and/or monitored from the administration of compositions contemplated herein.

[0039] As used herein, “about” means within a statistically meaningful range of a value or values such as a stated concentration, length, molecular weight, pH, sequence identity, timeframe, temperature or volume. Such a value or range can be within an order of magnitude, typically within 20%, more typically within 10%, and even more typically within 5% of a given value or range. The allowable variation encompassed by “about” will depend upon the particular system under study, and can be readily appreciated by one of skill in the art.

[0040] The following examples are presented to demonstrate preferred embodiments of the invention.

Example 1—Novel Low Blood Volume Collection Device with Conical-Shaped Cavity (Reservoir)

[0041] With reference to the figures, the present invention is directed to a collection device 100 configured for reliably and accurately approximately very low blood volume levels, such as detecting small amounts of blood in a liquid collected during a surgical procedure, and enabling visual estimation of blood loss. FIGS. 1-7 schematically illustrate collection device 100 with a cylindrical shape in accordance with selected embodiments of the present invention. It is also recognized that collection device 100 may have any other suitable shape and configuration in alternative embodiments not specifically disclosed herein.

[0042] As best shown in FIGS. 1 and 4, collection device 100 may include an enclosed perimeter sidewall 102 having an upper edge 104 and lower edge 106 defining an interior space or void 108 within collection device 100. Collection device 100 may further include a bottom disc or panel 110 enclosing the lower end of collection device 100 and interior space 108. Bottom panel 110 can have a circular shape and can be secured to lower edge 106 of sidewall 102 or integrally formed with sidewall 102 depending on the particular configuration. As best shown in FIG. 7, collection device 100 may additionally include an upper panel or lid 126 that can selectively enclose the upper end of collection device 100 and provide one or more inlet ports 128 for collection device 100 and configured to receive lengths of tubing 130 (which may be configured as aspiration tubing, inlet tubing for saline, or other types of tubing).

[0043] As further shown in FIGS. 1-7, collection device 100 may further include a lower sectional component or insert 112 disposed within interior space 108 and dividing interior space 108 into an upper region 108a and a lower region 108b. Depending on the particular embodiment of collection device 100, insert 112 may be removably or fixedly secured to the remainder of collection device 100 or integrally formed with the remainder of collection device 100. According to one embodiment of the present invention, insert 112 may be formed separately from the remainder of collection device 100 and inserted therein. According to another embodiment, insert 112 may be formed as part of the remainder of collection device 100.

[0044] As shown in FIGS. 1-7, insert 112 may include a top divider wall 114 intermediately positioned along the height of sidewall 102 and extending horizontally across sidewall 102. Top divider wall 114 may engage perimeter sidewall 102 around the entire perimeter of collection device 100 and form a physical barrier separating interior space 108 into its upper and lower regions 108a and 108b. Insert 112 may further include a conical-shaped cavity 116 defined into upper divider wall 114 and extending downward therefrom. Conical-shaped cavity 116 can include an upper circular opening 118 and a downwardly-depending conical sidewall 120 extending toward bottom panel 110 of collection device 100.

[0045] As best shown in FIGS. 1-3, according to one embodiment, conical-shaped cavity 116 may have a substantially smaller diameter than perimeter sidewall 102 (and upper divider wall 114) and may be centrally located within the interior of upper divider wall 114. Upper divider wall 114 may also have a slightly angled slope that extends at a downward angle toward conical-shaped cavity opening 118 in order to facilitate RBC sedimentation into conical-shaped cavity 116 (as described in greater detail below). In such an embodiment, conical-shaped cavity opening 118 is at an elevation slightly lower than the elevation of the outer perimeter edge of upper divider wall 114 where insert 112 engages sidewall 102 of collection device 100. It is also recognized that upper divider wall 114 may have any suitable arrangement or orientation in other embodiments of the present invention.

[0046] As best shown in FIGS. 4-6, according to another embodiment, conical-shaped cavity 116 may extend across all or a substantial portion of insert 112 and upper divider wall 114. As shown in FIGS. 4-6, conical-shaped cavity opening 118 may have a diameter substantially equal to or slightly less than upper divider wall 114, which engages perimeter sidewall 102 of collection device 100 in order to form the physical barrier separating interior space 108 into its upper and lower regions 108a and 108b.

[0047] As best shown in FIGS. 3 and 6, conical-shaped cavity 116 may include graduated markings in the form of a blood indicator panel (BIP) 122 positioned along the height of conical sidewall 120. Blood indicator panel 122 can extend completely or partially around conical sidewall 120 to provide a visual indication of the amount of blood and/or other fluids that have collected in conical-shaped cavity 116. In certain embodiments, blood indicator panel 122 may correspond to a volumetric amount (such as a volume of RBCs settled to the bottom of collection device 100). Blood indicator panel 122 may also be calibrated to correspond to a volume of blood contained within collection device 100 (based on a sedimented RBC volume as described in greater detail below). Collection device 100 may also include a fluid level panel 124 provided along the height of perimeter sidewall 102 in order to indicate the amount of total fluid or contents in the upper region 108a of collection device 100 (see FIG. 4). Collectively panels 122 and 124 may be used to identify the amount of blood and/or other fluids collected within the conical-shaped cavity 116 specifically and the overall collection device 100 generally.

[0048] Collection device 100 may be constructed from any suitable material, including plastic, glass, polymer-based material or other suitable material or any combination thereof. Collection device 100 may be sufficiently transparent or at least opaque so as to permit the visual detection of a level of material, such as sedimented RBCs, within collection device 100 and conical-shaped cavity 116.

Example 2—Use of RBC Flocculants with the Collection Device

[0049] According to certain embodiments, collection device 100 may be used with a RBC flocculent that facilitates the sedimentation of RBCs within the liquid provided into collection device 100. The particular RBC flocculant used with collection device 100 may be any suitable flocculant currently known or hereinafter developed. Non-limiting examples of potentially suitable flocculants may include: Polydiallyldimethylammonium chloride (PolyDADMAC); Polyethylenimine (PEI); Polyacrylamide (PAM); non-polymeric flocculants such as HCl and other acids; and the like. The RBC flocculant may further be used within collection device 100 in any suitable form, including without limitation, in solid form, in an aqueous solution, as a water-in-oil emulsion, or as a dispersion in water.

[0050] Normally, in the absence of a flocculant, the RBC sedimentation rate, or erythrocyte sedimentation rate (ESR) is relatively low, or not detectable to the unaided eye. As a result, it may take many hours or even days for RBCs to settle within the collection device 100 without centrifugation at room temperature in the absence of a flocculant. In the presence of an RBC flocculant, such as the RBC flocculant polyDADMAC, the RBC settlement rate can increase significantly. In the presence of an RBC flocculant, RBC sedimentation can occur in less than about 20 minutes, and formed a stable RBC sedimentation volume that was readily visible to the unassisted eye.

[0051] The RBC flocculant used in collection device 100 may be disposed within interior space 108 of collection device 100 in any suitable manner such that when a fluid potentially containing blood is inserted into collection device 100, the RBC flocculant may operate to facilitate the efficient sedimentation of RBCs within the fluid to determine an estimated blood volume as described herein.

[0052] According to one embodiment, the RBC flocculant may be applied to the sidewall 102 of collection device 100 in the form of a vertical flocculant band 132 (see FIG. 8). The width of band 132 can be based, at least in part, on the diameter of collection device 100 in order to optimize the concentration of RBC flocculant to volume of liquid within collection device 100. According to one embodiment, flocculant band 132 may have a one-inch width; however, band 132 may have any other desired width and may even have a non-uniform width along the height of sidewall 102 of collection device 100. Vertical flocculant band 132 may be applied to sidewall 102 in any suitable manner, such as by brushing, spraying, misting, taping or otherwise adhering the flocculant comprising band 132 to sidewall 102 of collection device 100.

[0053] According to an alternative embodiment (see FIG. 9), the RBC flocculant may be applied to the interior space 108 of collection device by applying a uniform (or non-uniform) coating of flocculant to a portion of or the entirety of interior space 108 of collection device 100. The flocculant coating may be applied in any suitable manner, including without limitation, using ultrasound atomization technology. In this embodiment, the applied flocculant may form essentially a flocculant band 132 that extends around the entirety of sidewall 102 of collection device 100.

[0054] In each configuration, the flocculant band or coating 132 extends upward along sidewall 102 and as a result, only the portion of flocculant band 132 that immersed by the fluid within collection device 100 is dissolved/released into the fluid to cause RBC sedimentation. The flocculant band or coating 132 may further be applied to the insert 112 and/or conical-shaped cavity 116 in selected embodiments. In this manner, the flocculant band 132 may allow for a controlled release of flocculant proportional to the volume of fluid (i.e., blood, saline, etc.) in collection device 100.

Example 3—Methods of Using the Collection Device of the Present Invention for Estimating Blood Loss

[0055] Collection device 100 may be used in connection with one or more methods for determining the amount of blood in a volume of liquid, including without limitation, determining the amount of blood loss of a patient during a surgical or other operating procedure. According to one method of the present invention, collection device 100 may be provided with an appropriate amount of RBC flocculant provided therein. The volume of liquid may then be inserted into the interior 108 of collection device 100. As a result of the RBC flocculant within collection device 100, the RBCs contained within any blood present the volume of liquid will settle toward the lower region 108b of collection device 100 through sedimentation and gravity. This process may be accomplished in less than an hour and as even as soon as 5-30 minutes after the volume of liquid is inserted into the collection device 100. During the sedimentation process, the RBCs within the volume of liquid with settle into the conical-shaped cavity 116 within collection device 100. After an appropriate amount of time as elapsed for stable sedimentation of RBCs within the volume of liquid, a settled RBC volume can be estimated using the graduated markings or BIP panel 122. These graduated markings 122 may be calibrated to provide a blood volume approximation contained within the volume of liquid and/or the blood volume approximation can be obtained based on the RBC volume using various formulas and methods. According to certain embodiments, the volume of blood may be determined using the teachings set forth in U.S. Pat. No. 10,401,347, the entire disclosure of which is incorporated herein by reference. According to certain embodiments, calibration of the graduated markings 122 to display the total blood volume (or blood loss volume) based on the volume of settled RBCs, the subject's hematocrit (Hct) value (or an average Hct determined from a number of similar subjects), and a packing ratio η, according to the following formula: V.sub.b=V.sub.m/(Hct×η), where V.sub.b is the total blood volume, V.sub.m is the sedimented RBC volume, Hct is the patient's calculated hematocrit, and η is the packing ration (which may be calculated based on the aspect ratio of the collection device 100 and one or more other variables). Any other suitable method for calibrating the graduated markings or BIP panel 122 may also be suitably used in accordance with the present invention.

Example 4—Methods for Estimating Blood Loss in Small Amounts of Fluid Volume

[0056] Collection device 100 may be sized and configured for use in situations where a small amount of blood volume must be determined from a volume of fluid. In a typical operating room setting, smaller volumes of fluid containing blood and other materials (tissue, urine, non-blood fluid, etc.) will be aspirated from a surgical field. The aspiration of these fluids results in an undetermined loss of blood from the patient. Collection device 100 according to the present invention may be sized and configured to accommodate the estimation of blood loss in these small, sometimes critical, volumes of collected fluid. According to one embodiment, collection device 100 may be sized to hold approximately 100 ml of fluid within interior space 108 of collection device 100. The interior space 108 of collection device 100 may then be provided with a RBC flocculant, such as polyDADMAC, and can be especially useful for determining blood volume in small amounts of collected fluid. This embodiment of collection device 100 may be used, for example, in pediatric applications (infant) as well as in low volume critical fluid collection procedures.

Example 5—Human Pediatric Applications for Use in Estimating Blood Loss

[0057] Collection device 100 and the methods described in accordance with the present invention may be used for efficient measurement of blood loss in a pediatric patient. As used in the present embodiment, a pediatric patient may be defined as an individual up to 12 years of age having a body weight of up to 70 to 80 pounds.

[0058] A person's total blood volume (TBV) is related to body weight. The TBV of a child is around 75-80 ml/kg and is higher in the neonatal period (from 85 ml/kg it rises to a peak of 105 ml/kg by the end of the first month and then drops progressively over ensuing months). Thus, the TBV of a 3.5-kg 2-week-old will be about 350 ml while that of a 10-kg 15-month-old will be about 800 ml.

[0059] Because of the much reduced total volume of blood in a pediatric patient, it is especially important to provide a blood collection and blood loss estimation system and device that are designed for estimating blood loss accurately from a smaller volume of blood collected from a pediatric patient. Accordingly, collection device 100 may be specifically designed for pediatric blood loss estimation therefore crafted as a container having the herein described flocculant and canister demarcations with a total volume capacity of less than 1000 ml, such as about 500 ml or even about 250 ml, in the case of an infant or neonate.

[0060] A large acute loss of blood volume in a pediatric patient may compromise the circulation, and therefore blood loss should be carefully monitored so as to be able to detect a volume of blood loss of about 12% of the TBV (around 10 ml/kg) of the specific pediatric patient, assuming the child is in a stable condition and has a normal blood hemoglobin (Hb) level at the beginning of a procedure.

[0061] By way of example, collection device 100 may, in some embodiments, have a capacity of 250 mLs. The collection device 100 according to such an embodiment would preferably provide an appropriate aspect ratio of D:H for a typical pediatric blood loss volume. The D (diameter) of the collection device 100 would typically be between 2 and 3 inches, and have an H (height) of about 2 inches to about 3 inches. With these smaller dimensions, a collected blood loss volume would provide a reasonably rapid yet monitorable sedimentation rate of RBCs so as to alert an attending physician if an amount of blood loss has reached a volume where transfusion to the pediatric patient is in order. It would be preferred that a sedimentation rate would be achieved that provides for RBC sedimentation within 15 minutes of blood collected in the collection device.

[0062] As described herein, collection device 100 may include a conical-shaped cavity 116 located within a lower interior region 108b of the interior 108 of collection device 100. The flocculant may be provided within the collection device 100 either at the time of the surgical intervention event, or may be provided as a pretreatment to the canister (such as by a spray coating) as described above.

[0063] The amount of flocculant to be added to a 250 ml collection device 100 according to certain embodiments may be about 50 mg to about 150 mg, or about 125 mg, or an amount sufficient to achieve at least a 0.3%, 0.4% or 0.75% of total volume of the solution.

[0064] According to one example, the following average total blood volume in a pediatric group of patients may be used in calculating when a 12% or greater blood loss has occurred. An average hematocrit value may also be calculated for the class/group (premature neonate, full term neonate, infant) of pediatric patients, and a marking provided alongside one axis of the collection device 100, of average hematocrit values for these patient groups, so as to provide a ready visual reference for the attending physician or anesthesiologist to refer to and compare as against the hematocrit obtained for the patient undergoing the procedure: [0065] Premature Neonates 95 ml/kg [0066] Full Term Neonates 85 ml/kg [0067] Infants 80 ml/kg

[0068] The total approximation of blood volume may be calculated by the formula described herein by using the average hematocrit of for a human child of a particular weight range and/or age, or for a human adult male or adult female, the V.sub.m (observable settled RBC volume in ml), and the packed ratio value (n) determined for human blood. With multiple human blood sample assessments of settled RBC volume (V.sub.m) and Hct information, a visual blood volume indicator panel 122 to be located along the vertical axis of the conical-shaped cavity 116 may be prepared for the human, and especially for a pediatric human model. This may provide an immediately visually discernable approximation of blood volume in volumes less than about 250 ml, contained in a biological fluid containing human blood. The development of a collection device 100 having a Blood Indicator Panel 122 for human blood volume assessment in a liquid, and especially for assessing small volumes of human blood loss, may be developed by one of ordinary skill in the art given the teachings provided herein, without more than a routine and ordinary amount of trial and error.

Example 6—Veterinary Applications for Use in Estimating Blood Loss

[0069] Collection device 100 and the methods described in accordance with the present invention may be used for efficient measurement of blood loss in a veterinary subject. As used in the present embodiment, a veterinary subject may be defined as a domestic or companion animal, such as a dog, cat, horse, rabbit, bird, or guinea pig, for example.

[0070] Domestic animals have blood volumes of 7%-9% of their body weight. For example, a 25-kg dog has a total blood volume of about 2 liters. In comparison, an adult human has a total blood volume of about 5 liters. Given the much lower total blood volume of domestic animals, important to provide a blood collection and blood loss estimation system and device that are designed for estimating blood loss accurately from a smaller volume of blood collected from a veterinary subject. Accordingly, collection device 100 may be specifically designed for veterinary blood loss estimation therefore crafted as a container having the herein described flocculant and canister demarcations with a total volume capacity of less than 2 L, for example. As described herein, collection device 100 may include a conical-shaped cavity 116 located within a lower interior region 108b of the interior 108 of collection device 100. The flocculant may be provided within the collection device 100 either at the time of the surgical intervention event, or may be provided as a pretreatment to the canister (such as by a spray coating) as described above.

Example 7—Blood Loss Collection Kit Using the Collection Device

[0071] The collection device 100 of the present invention may be configured as a collection kit or system for receiving a volume of liquid from a patient and potentially containing blood and determining the amount of blood loss of the patient in accordance with one embodiment of the present invention. As best shown in FIG. 7, collection device 100 may be constructed and configured in as described herein with a conical-shaped cavity 116 and a blood indicator panel 122. According to this embodiment and as further shown in FIG. 7, collection device 100 may further include a lid or top panel 126, a pair of inlet ports 128 defined though lid 126 and lengths of tubing 130 suitable connected to inlet ports 128. One length of tubing 130 may be configured for aspiration from the patient (or operating site) to the interior 108 of collection device 100 and the second length of tubing 130 may be configured for adding saline into the collection device 100. Upon receiving a volume of fluid (via lengths of tubing 130) within collection device 100, the total blood loss volume may be determine using the blood indicator panel 122 and the methods described herein.

[0072] The examples set forth above are provided to give those of ordinary skill in the art a complete disclosure and description of how to make and use the embodiments of the methods for prediction of the selected modifications that may be made to a biomolecule of interest, and are not intended to limit the scope of what the inventors regard as the scope of the disclosure. Modifications of the above-described modes for carrying out the disclosure can be used by persons of skill in the art, and are intended to be within the scope of the following claims.

[0073] It is to be understood that the disclosure is not limited to particular methods or systems, which can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.

[0074] A number of embodiments of the disclosure have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the present disclosure. Accordingly, other embodiments are within the scope of the following claims.